EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial Activity of Hydralazine Against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus

Francisca B Stefany Aires do Nascimento iD, Lívia Gurgel do Amaral Valente Sá iD, João B de Andrade Neto iD, Lisandra Juvêncio da Silva iD, Daniel Sampaio Rodrigues iD, Vitória P de Farias Cabral iD, Amanda Dias Barbosa iD, Lara E Almeida Moreira iD, Camille R Braga Vasconcelos, Bruno Coêlho Cavalcanti iD, Maria E França Rios, Jacilene Silva iD und 7 weitere

Future Microbiology · 2024

DOI: 10.2217/fmb-2023-0160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Microbiology, 2024. Verfasst von Francisca B Stefany Aires do Nascimento und 18 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Laboratory of Bioprospection of Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, 60430-372, Brazil. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Staphylococcus aureus is a human pathogen responsible for high mortality rates. The development of new antimicrobials is urgent. Materials & methods: The authors evaluated the activity of hydralazine along with its synergism with other drugs and action on biofilms. With regard to action mechanisms, the authors evaluated cell viability, DNA damage and molecular docking.

Results

MIC and minimum bactericidal concentration values ranged from 128 to 2048 μg/ml. There was synergism with oxacillin (50%) and vancomycin (25%). Hydralazine reduced the viability of biofilms by 50%. After exposure to hydralazine 2× MIC, 58.78% of the cells were unviable, 62.07% were TUNEL positive and 27.03% presented damage in the comet assay (p < 0.05). Hydralazine showed affinity for DNA gyrase and TyrRS.

Conclusion

Hydralazine is a potential antibacterial. Staphylococcus aureus is a bacterium that can cause infection. Infections of S. aureus are becoming difficult to treat, but developing new drugs is a challenge. Repurposing them may be easier. This study looks at the possibility of using hydralazine, a type of medicine used to treat high blood pressure, against S. aureus. The authors found that hydralazine can kill S. aureus and can be used with other antibiotics, including oxacillin and vancomycin. Hydralazine interferes with important processes for the multiplication and survival of this bacterium. These results are preliminary but encouraging. Further studies are needed to confirm the use of hydralazine as a new treatment for S. aureus infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsHumansStaphylococcus aureusMethicillinMethicillin ResistanceMolecular Docking SimulationAnti-Bacterial AgentsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

DNA fragmentationMRSAMSSATyrRSgyrase Ahydralazinerepurposing

Substanzen

MethicillinAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Pharmacy, Laboratory of Bioprospection of Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, 60430-372, Brazil.
  • Drug Research & Development Center, Federal University of Ceará, Fortaleza, CE, 60430-275, Brazil.
  • Christus University Center (UNICHRISTUS), Fortaleza, CE, 60190-180, Brazil.
  • Department of Physiology & Pharmacology, Federal University of Ceará, Fortaleza, CE, 60430-275, Brazil.
  • Department of Chemistry, Group of Theoretical Chemistry & Electrochemistry (GQTE), State University of Ceará, Limoeiro do Norte, Ceará, 62930-000, Brazil.
  • Science & Technology Centre, Course of Chemistry, State University Vale do Acaraú, Sobral, CE, 62010-560, Brazil.

ORCID-Profile: Francisca B Stefany Aires do Nascimento, Lívia Gurgel do Amaral Valente Sá, João B de Andrade Neto, Lisandra Juvêncio da Silva, Daniel Sampaio Rodrigues, Vitória P de Farias Cabral, Amanda Dias Barbosa, Lara E Almeida Moreira, Bruno Coêlho Cavalcanti, Jacilene Silva, Emmanuel Silva Marinho, Helcio Silva Dos Santos, Marina Duarte Pinto Lobo, Manoel Odorico de Moraes, Hélio V Nobre Júnior, Cecília Rocha da Silva

Zitieren

APA

Stefany Aires do Nascimento, F. B., do Amaral Valente Sá, L. G., de Andrade Neto, J. B., da Silva, L. J., Rodrigues, D. S., de Farias Cabral, V. P., Barbosa, A. D., Almeida Moreira, L. E., Braga Vasconcelos, C. R., Cavalcanti, B. C., França Rios, M. E., Silva, J., Marinho, E. S., Dos Santos, H. S., de Mesquita, J. R., Pinto Lobo, M. D., de Moraes, M. O., Nobre Júnior, H. V., & da Silva, C. R. (2024). Antimicrobial Activity of Hydralazine Against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus. Future Microbiology. https://doi.org/10.2217/fmb-2023-0160

Vancouver

Stefany Aires do Nascimento FB, do Amaral Valente Sá LG, de Andrade Neto JB, da Silva LJ, Rodrigues DS, de Farias Cabral VP, et al. Antimicrobial Activity of Hydralazine Against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus. Future Microbiology. 2024. doi:10.2217/fmb-2023-0160

BibTeX
@article{StefanyAiresdoNascimento2024,
  author = {Stefany Aires do Nascimento, Francisca B and do Amaral Valente Sá, Lívia Gurgel and de Andrade Neto, João B and da Silva, Lisandra Juvêncio and Rodrigues, Daniel Sampaio and de Farias Cabral, Vitória P and Barbosa, Amanda Dias and Almeida Moreira, Lara E and Braga Vasconcelos, Camille R and Cavalcanti, Bruno Coêlho and França Rios, Maria E and Silva, Jacilene and Marinho, Emmanuel Silva and Dos Santos, Helcio Silva and de Mesquita, Jacó Rl and Pinto Lobo, Marina Duarte and de Moraes, Manoel Odorico and Nobre Júnior, Hélio V and da Silva, Cecília Rocha},
  title = {Antimicrobial Activity of Hydralazine Against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus},
  journal = {Future Microbiology},
  year = {2024},
  doi = {10.2217/fmb-2023-0160}
}
Kostenlos starten →